DIAGNOS Stock Forecast, Price & News

DIAGNOS (CVE:ADK) Frequently Asked Questions

What stocks does MarketBeat like better than DIAGNOS?

Wall Street analysts have given DIAGNOS a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but DIAGNOS wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is DIAGNOS's next earnings date?

DIAGNOS is scheduled to release its next quarterly earnings announcement on Wednesday, November 24th 2021.
View our earnings forecast for DIAGNOS.

How were DIAGNOS's earnings last quarter?

DIAGNOS Inc. (CVE:ADK) issued its earnings results on Tuesday, August, 10th. The company reported ($0.01) earnings per share (EPS) for the quarter. The business had revenue of $0.08 million for the quarter.
View DIAGNOS's earnings history.

How has DIAGNOS's stock price been impacted by Coronavirus?

DIAGNOS's stock was trading at C$0.22 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, ADK shares have increased by 131.8% and is now trading at C$0.51.
View which stocks have been most impacted by COVID-19.

Who are DIAGNOS's key executives?

DIAGNOS's management team includes the following people:

• Mr. Andre Larente, CEO, Pres & Exec. Director
• Mr. Marc-André Massue, VP of Fin., CFO & Sec.
• Mr. Guillermo Moreno Robles, VP of Sales

Who are some of DIAGNOS's key competitors?

Some companies that are related to DIAGNOS include Vitalhub (VHI), Induction Healthcare Group (INHC), IQ-AI (IQAI), CardioComm Solutions (EKG), ZoomMed (ZMD), 1st Group (1ST), Alcidion Group (ALC), Binovi Technologies (BNVIF), Cann American (CNNA), Carebook Technologies (CRBKF), CloudMD Software & Services (DOCRF), Cogstate (CGS), Corum Group (COO), EGF Theramed Health (EVAHF) and Emyria (EMD).
View all of ADK's competitors.

What other stocks do shareholders of DIAGNOS own?

Based on aggregate information from My MarketBeat watchlists, some companies that other DIAGNOS investors own include Marijuana Company of America (MCOA), Maxar Technologies (MAXR) and Main Street Capital (MAIN).

What is DIAGNOS's stock symbol?

DIAGNOS trades on the Canadian Venture Exchange (CVE) under the ticker symbol "ADK."

How do I buy shares of DIAGNOS?

Shares of ADK and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is DIAGNOS's stock price today?

One share of ADK stock can currently be purchased for approximately C$0.51.

How much money does DIAGNOS make?

DIAGNOS has a market capitalization of C$34.84 million and generates C$295,344.00 in revenue each year.

What is DIAGNOS's official website?

The official website for DIAGNOS is www.diagnos.ca.

Where are DIAGNOS's headquarters?

DIAGNOS is headquartered at 7005 Taschereau Blvd, Suite 340 Brossard, BROSSARD, QC J4Z 1A7, Canada.

How can I contact DIAGNOS?

DIAGNOS's mailing address is 7005 Taschereau Blvd, Suite 340 Brossard, BROSSARD, QC J4Z 1A7, Canada. The company can be reached via phone at +1-450-6788882.